Allergies News and Research

Latest Allergies News and Research

Researchers identify gene used to recognize pathogens

Researchers have identified a gene in the Anopheles gambiae mosquito's DNA that is central to the insect's ability to defend against infectious pathogens, including Plasmodium, the parasite that causes malaria in humans.

20 Jun 2006

Bioinformatics used to advance human disease research

The use of computers to advance human disease research - known as bioinformatics -- has received a major boost from researchers at the La Jolla Institute for Allergy & Immunology (LIAI).

18 Jun 2006

Study finds high mold levels in post-Katrina New Orleans air

Airborne mold levels left in New Orleans pose a "significant respiratory hazard" to residents returning to the devastated city in the aftermath of Hurricane Katrina.

18 Jun 2006

Exposure to airborne fungal spores increase kids' risk for multiple allergies

University of Cincinnati (UC) researchers say exposure to a certain group of fungal spores - abundant in the air that we breathe every day - can make young children more susceptible to developing multiple allergies later in life.

14 Jun 2006

Lessons from our patients: development of a warm autopsy program

Thanks in large part to a dying patient's generosity, researchers have for the first time begun to analyze the progression of idiopathic pulmonary fibrosis (IPF), a degenerative illness distinguished by lung inflammation, scarring and diminished breathing capacity that typically leads to death within about five years of diagnosis.

7 Jun 2006

MS sufferers relieved as drug Tysabri goes back on the market

The Food and Drug Administration in the U.S. has given it's approval for the multiple sclerosis drug Tysabri to be put back on the market.

6 Jun 2006

Study finds ways to improve detection of blood clots in the lung

Largest study ever conducted to assess the role of contrast-enhanced multidetector computed tomographic (CT) angiography for diagnosing pulmonary embolism.

5 Jun 2006

West Nile virus DNA vaccine shows promise in phase 1 trial

Vical Incorporated has announced that in a Phase 1 clinical trial, a West Nile virus (WNV) vaccine candidate administered using Vical's proprietary DNA delivery technology was safe and well tolerated

5 Jun 2006

Misuse of ADHD drugs sends thousands each year to seek emergency hospital treatment

Scientists at the U.S. Centers for Disease Control and Prevention (CDC) have estimated that problems with the drugs used to treat attention deficit disorders force as many as 3,100 people to seek emergency hospital treatment each year.

25 May 2006

Higher dose of flu vaccine improves immune response in the elderly

There may be a simple way to provide elderly Americans with extra protection against the annual flu virus: give them a higher dose of seasonal flu vaccine.

23 May 2006

Exposure to cats early in life may raise childs' risk of eczema

According to new study in the U.S. children who are exposed to cats soon after birth may have an increased risk of developing eczema, while being exposed to two or more dogs at home may offer some slight protection.

23 May 2006

Environmental tobacco smoke drastically increases an infant's risk for developing allergic rhinitis

University of Cincinnati (UC) epidemiologists say it's environmental tobacco smoke--not the suspected visible mold--that drastically increases an infant's risk for developing allergic rhinitis by age 1.

17 May 2006

Peanut - kiss not the culprit in Canadian teens death

According to a coroner in Quebec a severe asthma attack was responsible for the death of a 15 year old girl last November and not a peanut-contaminated kiss.

14 May 2006

Abortion pill in trouble again

Clostridium sordellii is a rare germ that has killed four women who took the abortion pill RU-486 and has also been implicated in the deaths of at least 11 other women following childbirth or miscarriage.

11 May 2006

Europe-wide study into the role of genetics and the environment in the development asthma

Previous investigations have fallen short of proving cause-effect due to the complexity of human genetics and varying lifestyles. But the EU-funded GABRIEL study has pooled the very best in the field from all over Europe and can draw on the latest genomic and environmental data and approaches.

11 May 2006

Inhaled corticosteroids can reduce breathing problems in children at high risk for asthma

Studies in older children and adults show that the most effective long-term control medicine for persistent asthma (symptoms more than two days a week or more than twice a month at night) is inhaled corticosteroids, which reduce airway swelling and help prevent asthma symptoms (e.g., asthma attacks).

10 May 2006

Off-label prescribing common, often not backed by data

A study of office-based physicians in the United States suggests that about one-fifth of medications are prescribed to treat conditions for which they are not approved by the U.S. Food and Drug Administration (FDA), and that nearly three-fourths of those uses lack strong scientific support, according to an article in the May 8 issue of Archives of Internal Medicine.

9 May 2006

Europe wide study to examine causes of asthma

The GABRIEL project, funded through an EC Framework 6 grant, involves over 150 scientists from 14 European countries and Russia, using the latest research across a variety of disciplines, including genetics, epidemiology and immunology, to identify key factors in the development of asthma bronchiale.

9 May 2006

Allergy-free soybeans

Researchers have isolated two Chinese soybean lines that grow without the primary protein linked to soy allergies in children and adults.

8 May 2006

Bronchial thermoplasty offers significant improvement for asthmatics

Asthmatic patients showed significant improvement in peak expiratory flow, airway responsiveness and number of symptom-free days after treatment with bronchial thermoplasty, a new procedure designed to reduce the ability of airway smooth muscle to narrow from inflammation.

3 May 2006